Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Heat Biologics Inc (HTBX)

7.68   -0.23 (-2.91%) 03-07 04:44
Open: 7.8 Pre. Close: 7.91
High: 7.88 Low: 6.7299
Volume: 1,567,094 Market Cap: 175M
Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company is headquartered in Durham, North Carolina and currently employs 30 full-time employees. The firm is an immuno-oncology company, which focuses on T cell-stimulating platform technologies, such as Immune Pan-Antigen Cytotoxic Therapy (ImPACT) and Combination Pan-Antigen Cytotoxic Therapy (ComPACT). Using its ImPACT platform technology, the Company has developed HS-410 (vesigenurtacel-L) as a product candidate to treat non-muscle invasive bladder cancer (NMIBC), and HS-110 (viagenpumatucel-L), which is intended for use in combination with an anti-PD-1 checkpoint inhibitor, as a potential treatment for patients with non-small cell lung cancer (NSCLC). Using its ComPACT platform technology, it has developed HS-120 as a potential treatment for NSCLC. The company is conducting a Phase II trial of HS-410 in patients with NMIBC, and a Phase Ib trial of HS-110, in combination with nivolumab (Opdivo) to treat patients with NSCLC.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.889 - 7.939 7.939 - 7.974
Low: 6.628 - 6.681 6.681 - 6.719
Close: 7.6 - 7.689 7.689 - 7.752

Technical analysis

as of: 2021-03-05 5:09:07 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 15.20     One year: 19.86
Support: Support1: 6.56    Support2: 5.46
Resistance: Resistance1: 13.01    Resistance2: 17.00
Pivot: 8.87
Moving Average: MA(5): 8.05     MA(20): 9.22
MA(100): 7.58     MA(250): 7.60
MACD: MACD(12,26): -0.02     Signal(9): 0.25
Stochastic oscillator: %K(14,3): 14.26     %D(3): 11.43
RSI: RSI(14): 44.79
52-week: High: 30.10  Low: 3.22  Change(%): 27.6
Average Vol(K): 3-Month: 317008  10-Days: 149254

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
HTBX has closed above bottom band by 22.9%. Bollinger Bands are 62.5% wider than normal. The large width of the bands suggest high volatility as compared to HTBX's normal range. The bands have been in this wide range for 17 bars. This is a sign that the current trend might continue.

Headline News

Wed, 03 Mar 2021
Should You Buy Heat Biologics Inc (HTBX) Stock Wednesday Morning? - InvestorsObserver

Wed, 03 Mar 2021
Heat Biologics (HTBX) Jumps Sharply On Sudden Stock Upgrade – Own Snap - Own Snap

Fri, 26 Feb 2021
Heat Biologics - Consensus Indicates Potential 245.7% Upside - DirectorsTalk Interviews

Fri, 26 Feb 2021
$590,000.00 in Sales Expected for Heat Biologics, Inc. (NASDAQ:HTBX) This Quarter - MarketBeat

Thu, 18 Feb 2021
Heat Biologics - Consensus Indicates Potential 155.9% Upside - DirectorsTalk Interviews

Tue, 16 Feb 2021
HTBX: HS-110 Phase 2 Interim Data - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 23
Shares Float (M) 22
% Held by Insiders 3.01
% Held by Institutions 12.27
Shares Short (K) 2,100
Shares Short P. Month (K) 2,180

Stock Financials

EPS -1.990
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 5.420
Profit Margin
Operating Margin -496.59
Return on Assets (ttm) -17.5
Return on Equity (ttm) -33.7
Qtrly Rev. Growth 13096.6
Gross Profit (p.s.) -0.436
Sales Per Share 0.190
EBITDA (p.s.) -0.932
Qtrly Earnings Growth
Operating Cash Flow (M) -16
Levered Free Cash Flow (M) -10

Stock Valuations

PE Ratio -3.86
PEG Ratio
Price to Book value 1.42
Price to Sales 40.40
Price to Cash Flow -11.08

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.